{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:54:16Z","timestamp":1791154456286,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/wno.0b013e3181f7f833","type":"journal-article","created":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T10:40:25Z","timestamp":1289904025000},"page":"328-339","source":"Crossref","is-referenced-by-count":178,"title":["Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple Sclerosis"],"prefix":"10.1097","volume":"30","author":[{"given":"Kenneth S","family":"Shindler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahasweta","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise C","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolmohamad","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210126","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis.","volume":"343","author":"Noseworthy","year":"2002","journal-title":"N Eng J Med"},{"key":"R2-7-20210126","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/brain\/118.6.1583","article-title":"Persistent functional deficit in multiple sclerosis and autosomal dominant ataxia associated with axon loss.","volume":"118","author":"Davie","year":"1995","journal-title":"Brain"},{"key":"R3-7-20210126","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/119.3.701","article-title":"Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression.","volume":"119","author":"Losseff","year":"1996","journal-title":"Brain"},{"key":"R4-7-20210126","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/brain\/119.6.2009","article-title":"Progressive cerebral atrophy in multiple sclerosis: a serial MRI study.","volume":"119","author":"Losseff","year":"1996","journal-title":"Brain"},{"key":"R5-7-20210126","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","article-title":"Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.","volume":"113","author":"Fisher","year":"2006","journal-title":"Ophthalmology"},{"key":"R6-7-20210126","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00415-003-0965-8","article-title":"Beta-interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.","volume":"250","author":"Parry","year":"2003","journal-title":"J Neurol"},{"key":"R7-7-20210126","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/jnnp.74.8.1139","article-title":"Corticosteroids do not prevent optic nerve atrophy following optic neuritis.","volume":"74","author":"Hickman","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R9-7-20210126","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","article-title":"Wolinsky JS; the Copolymer 1 Multiple Sclerosis Study Group. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial.","volume":"45","author":"Johnson","year":"1995","journal-title":"Neurology"},{"key":"R10-7-20210126","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jnnp.64.4.505","article-title":"Measurement of the retinal nerve fibre layer with scanning laser polarimetry in patients with previous demyelinating optic neuritis.","volume":"64","author":"Steel","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R11-7-20210126","first-page":"2520","article-title":"Correlation between morphological and functional retinal impairment in multiple sclerosis patients.","volume":"40","author":"Parisi","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-7-20210126","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.20575","article-title":"Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis.","volume":"58","author":"Trip","year":"2005","journal-title":"Ann Neurol"},{"key":"R13-7-20210126","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography.","volume":"59","author":"Costello","year":"2006","journal-title":"Ann Neurol"},{"key":"R14-7-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF02786446","article-title":"Pathogenesis of neuroimmunologic diseases.","volume":"17","author":"Constantinescu","year":"1998","journal-title":"Immunol Res"},{"key":"R15-7-20210126","first-page":"1717","article-title":"Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein.","volume":"33","author":"Potter","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-7-20210126","doi-asserted-by":"crossref","first-page":"13847","DOI":"10.1073\/pnas.95.23.13847","article-title":"Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis.","volume":"95","author":"Guy","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-7-20210126","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/1352458506070629","article-title":"Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis.","volume":"12","author":"Shindler","year":"2006","journal-title":"Mult Scler"},{"key":"R18-7-20210126","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1167\/iovs.07-0131","article-title":"SIRT1 activation confers neuroprotection in experimental optic neuritis.","volume":"48","author":"Shindler","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-7-20210126","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35001622","article-title":"Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.","volume":"403","author":"Imai","year":"2000","journal-title":"Nature"},{"key":"R20-7-20210126","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1073\/pnas.110148297","article-title":"The silencing protein SIR2 and its homologs are NAD dependent protein deacetylases.","volume":"97","author":"Landry","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-7-20210126","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1073\/pnas.97.12.6658","article-title":"A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family.","volume":"97","author":"Smith","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-7-20210126","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature06261","article-title":"Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.","volume":"450","author":"Milne","year":"2007","journal-title":"Nature"},{"key":"R23-7-20210126","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.4049\/jimmunol.169.12.7104","article-title":"IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.","volume":"169","author":"Gran","year":"2002","journal-title":"J Immunol"},{"key":"R24-7-20210126","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1167\/iovs.04-0554","article-title":"Myelin\/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL\/6 mouse.","volume":"45","author":"Shao","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R25-7-20210126","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.exer.2008.05.017","article-title":"Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis.","volume":"87","author":"Shindler","year":"2008","journal-title":"Exp Eye Res"},{"key":"R26-7-20210126","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2353\/ajpath.2006.051309","article-title":"Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1--D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.","volume":"169","author":"Paintlia","year":"2006","journal-title":"Am J Pathol"},{"key":"R27-7-20210126","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.179.5.3268","article-title":"Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis.","volume":"179","author":"Fitzgerald","year":"2007","journal-title":"J Immunol"},{"key":"R28-7-20210126","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mnfr.200500022","article-title":"Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications.","volume":"49","author":"de la Lastra","year":"2005","journal-title":"Mol Nutr Food Res"},{"key":"R29-7-20210126","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/sj.emboj.7601633","article-title":"Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1.","volume":"26","author":"Gerhart-Hines","year":"2007","journal-title":"EMBO J"},{"key":"R30-7-20210126","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1124\/mol.107.038984","article-title":"Resveratrol (trans-3,5,4-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor.","volume":"72","author":"Singh","year":"2007","journal-title":"Mol Pharmacol"},{"key":"R31-7-20210126","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.intimp.2008.10.015","article-title":"Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.","volume":"9","author":"Imler","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"R32-7-20210126","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1750-3639.2004.tb00047.x","article-title":"Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis.","volume":"14","author":"Hobom","year":"2004","journal-title":"Brain Pathol"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNO.0b013e3181f7f833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:41:44Z","timestamp":1620978104000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041327-201012000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e3181f7f833","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}